Search for: "Novartis Ag"
Results 381 - 400
of 440
Sort by Relevance
|
Sort by Date
7 Nov 2008, 2:54 pm
Novartis Consumer Health, Inc., --- F. [read post]
4 Nov 2008, 11:52 am
The hearings are to decide appeal filed by Novartis AG challenging the Indian Patent Controller's decision to reject its patent application for the beta-crystalline form of Imatinib Mesylate (Gleevec). [read post]
10 Oct 2008, 3:22 pm
There is always an ounce of concern among manufacturers about consumer safety, and a pound of worry about the results of statistical risk benefit analyses attached to products. [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
25 Sep 2008, 10:06 am
Reflections on the Interpretation of Article 27 TRIPS from Novartis v. [read post]
26 Aug 2008, 3:28 pm
This one involves Sandoz, the generic drug unit of Novartis AG (NVS), and its metoprolol succinate ER tablets, which is a generic form of AstraZeneca's Toprol XL. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
15 Aug 2008, 12:52 pm
The Editorial Board of SCRIPTed - A Journal of Law, Technology & Society is pleased to present its 18th issue, which addresses issues ranging from challenges in medical research governance in Korea, to pharmaceutical litigation (an assessment of the Novartis case in India), to data-protection of administrative records, to privacy in the age of sophisticated location-based technologies, to governance of the mobile communication sector in Korea and US, to a follow-up on our… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Discussion and analysis of WTO Ministerial meeting progress on TRIPs issues: (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (IP Updates), Italian broadcaster, Mediaset sues Google for hosting video clips on… [read post]
23 Jul 2008, 5:00 am
Novartis Pharmaceuticals Corp., No. 05-5350, 2008 WL 2683047 (E.D. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
20 Jun 2008, 8:07 am
: (Electronic Frontier Foundation) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 23 June: US LSI: ‘Multilateral patents’ – San Francisco: (Patent Docs), 23 June: STEP / Committee on National Statistics conference on ‘Intangible assets: measuring and enhancing their contribution to corporate value and economic… [read post]
13 Jun 2008, 3:40 am
’ – London: (IPKat), 18 June: CC technology summit – California: (creativecommons.org), 18-20 June: IIR generic drugs summit – Washington: (Orange Book Blog), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of patent prosecution 2008: A boot camp for claim drafting & amendment writing’ – New York / San Francisco: (Patent Docs), 19-20 June: 27th ECTA Conference ‘Forty shades of green: a tour of the IP… [read post]
7 Jun 2008, 3:34 am
Yesterday, Forbes.com reported that Novartis AG spent almost $1.3 million in the first quarter of 2008 on lobbying. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
1 May 2008, 11:21 am
One of the ways we feed this blog is doing what comes naturally to us lawyers - reading recent cases - and hoping that something inspires us. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
17 Apr 2008, 10:39 am
Novartis Pharmaceuticals Corp., ___ F. [read post]
7 Apr 2008, 9:32 pm
Singer -- In April 7, 2008 press releases from Novartis AG and Alcon Inc., the companies announced that Novartis has reached an agreement with Nestlé S.A. which provides Novartis with the right to acquire majority ownership of Alcon Inc. [read post]
